No abstract available
MeSH terms
-
Condylomata Acuminata / economics
-
Condylomata Acuminata / prevention & control
-
Cost-Benefit Analysis
-
Female
-
Health Policy
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Papillomavirus Infections / prevention & control*
-
Papillomavirus Vaccines / economics*
-
United Kingdom
-
Uterine Cervical Neoplasms / prevention & control
Substances
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines
-
human papillomavirus vaccine, L1 type 16, 18